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The diversity and dynamics of the skin microbiome in 
health and disease have been studied recently, but ade-
quate model systems to study skin microbiotas in vitro 
are largely lacking. We developed an in vitro system that 
mimics human stratum corneum, using human callus as 
substrate and nutrient source for bacterial growth. The 
growth of several commensal and pathogenic bacterial 
strains was measured for up to one week by counting co-
lony-forming units or by quantitative PCR with strain-
specific primers. Human skin pathogens were found to 
survive amidst a minimal microbiome consisting of 2 
major skin commensals: Staphylococcus epidermidis and 
Propionibacterium acnes. In addition, complete microbi-
omes, taken from the backs of healthy volunteers, were 
inoculated and maintained using this system. This model 
may enable the modulation of skin microbiomes in vi-
tro and allow testing of pathogens, biological agents and 
antibiotics in a medium-throughput format. Key words: 
skin; callus; bacteria; microbiome; antibiotics.
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The skin is a physical barrier that protects the interior of 
the human body from the exterior. It supports a complex 
microbial ecosystem that is in homeostasis with its host 
(1). The microbial communities residing on the skin have 
been investigated recently using culture-independent 
methods (2, 3). These communities, termed microbiotas, 
are considered beneficial for our health (4). Furthermore, 
disturbance of “normal” microbial communities, a condi-
tion called “dysbiosis”, in which homeostatic relations 
between the host and its microbiota are disturbed, is 
associated with skin diseases (5). Skin microbiotas are 
therefore being studied in a search for markers related to 
disease onset, progression, and outcome, which may lead 
to the development of novel therapies for skin diseases.
Different factors influence the microbiota composi-
tion of the skin; for example, lifestyle, host demogra-
phic and environmental characteristics, the use of anti-
bacterial agents, and health status (6–9). Skin alterations 
and dysregulated immune responses could cause shifts 
in the microbiota composition (10–14) and, on the other 
hand, skin microbiotas can modulate cutaneous immu-
nity (15–17). The microbial diversity of lesional skin is 
altered in inflammatory skin diseases, such as psoriasis 
and atopic dermatitis (12, 18–20). However, it is not 
known if these shifts in bacterial composition have a 
causal role in disease or are merely a consequence of 
disturbed skin homeostasis.
Changes in bacterial diversity, microbiota composi-
tion, and host-defence interactions in health and disease 
can be studied using skin models. For instance, human 
reconstructed skin models and ex vivo skin models 
have been used to study the efficacy of antibacterial 
compounds (21–24) or the colonization and infection 
characteristics of certain pathogens (25–29). However, 
these models are laborious, expensive, prone to bacterial 
overgrowth, and their throughput is low.
Under normal skin conditions, most of the bacteria 
reside in the upper half of the stratum corneum (10), fee-
ding on nutrients derived from the corneocytes, which 
consist mainly of cross-linked protein and lipids. The 
current study investigated whether human callus could 
serve as a substitute for stratum corneum to support the 
growth of skin commensals and pathogens, for use as a 
model for investigating bacterial growth, and assessing 
the efficacy of antimicrobial compounds.
MATERIALS AND METHODS
Callus collection and preparation
Human callus from the heels of 3 healthy volunteers was col-
lected using a callus rasp (Ped Egg™). The callus was mixed, 
frozen in liquid nitrogen, then ground up using a Micro Dis-
membrator U (B. Braun Biotech International, Melsungen, 
Germany), as described previously (30). Phosphate-buffered 
saline (PBS; Fresenius Kabi GmbH, Graz, Austria) was added 
to the callus powder to create a 2% suspension, which was 
sterilized by exposure to gamma radiation (16.2 kGy/63 h). 
The sterilized callus suspension was stored at 4°C or –20°C 
until further use.
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Preparation of the in vitro skin model
Sterile agar (2% in PBS; Becton, Dickinson and Co., Sparks, 
MD, USA) was added to wells of 24-well (1 ml agar) and 
96-well (100 µl agar) cell culture plates. A 100 µl (24-well) 
or 20 µl (96-well) volume of sterile callus suspension (2% in 
PBS) was applied on top of the agar. The plates were allowed 
to dry for 24 h at 37°C, and stored at 4°C until further use. For 
schematic representation see Fig. 1.
Bacterial cultures
Staphylococcus epidermidis (ATCC 12228), Propionibacterium 
acnes (ATCC 6919), Staphylococcus aureus (ATCC 29213), Pseu-
domonas aeruginosa (ATCC 27853) and Streptococcus pyogenes 
(ATCC 12344) strains were obtained from the Department of 
Medical Microbiology of the Radboud University Medical Center. 
Bioluminescent S. aureus (Xen36) was purchased from Caliper 
Life Sciences (Boston, MA, USA). Bacteria were inoculated on 
Columbia agar with 5% sheep blood (Becton, Dickinson and 
Co.) overnight at 37°C. A single colony of each plate was picked 
and cultured in brain heart infusion medium (Mediaproducts 
BV, Groningen, The Netherlands) overnight at 37°C, except for 
P. acnes, which was cultured in thioglycollate medium (Becton, 
Dickinson and Co.) under anaerobic conditions for 2 days at 37°C. 
Bacterial suspensions were diluted 10 times in medium and allo-
wed to grow for another 3 h to reach exponential bacterial growth 
(except for P. acnes). Thereafter, the bacteria were collected by 
centrifugation, washed twice with PBS and finally resuspended 
in PBS, resulting in bacterial concentrations of 104~1012 colony-
forming units (CFU)/ml. Bacterial suspension aliquots, 20 µl or 
5 µl, were added to each well of the callus model (in 24-well and 
96-well plates, respectively). When a mixture of bacterial strains 
was examined on the model, the same total number of CFU of 
every strain was used. The bacteria on the model were incubated 
at 32°C for different time-points for up to one week.
Counting colony-forming units 
The entire model (agar + callus + bacteria) was lifted out of the 
24-well plate and transferred to a 50 ml tube containing 10 ml 
PBS (Fig. S11). The tubes were vortexed at maximum speed for 
1 min to detach and suspend the bacteria. The aqueous solution 
containing the bacteria (including some callus particles, but with-
out the agar) was transferred to a new tube. These samples were 
serially diluted in steps of 10. Ten µl of each dilution was placed 
on sheep blood agar plates and incubated overnight at 37°C. Next 
day, visible colonies on the plate were counted for each dilution. 
Microbiome samples
Microbiome samples from the lower backs of 2 male volunteers 
were collected by swabbing the skin with Sample Collection 
Swabs (Epicentre Biotechnologies, Madison, WI, USA), as 
described previously (10). The swabs were collected in PBS, 
centrifuged for 5 min at 5000 rpm, resuspended in 60 µl PBS 
and divided over the model in 20 µl fractions. The model was 
incubated at 32°C for 1 week. Samples were collected for pro-
pidium monoazide (PMA)-quantitative PCR (qPCR) analysis 
and PMA-Illumina sequencing on days 0, 1 and 7.
Antibiotics
Tetracycline (Sigma-Aldrich, Zwijndrecht, The Netherlands) 
was added in different concentrations to the agar (2% agar 
in PBS). Callus and bacterial suspensions were added to the 
model as described above. Bacterial survival was assessed by 
counting CFU after culturing for 24 h. 
Propidium monoazide treatment
PMA treatment of collected bacteria was performed to eliminate 
microbial genomic DNA (gDNA) originating from non-viable 
cells. Bacteria were collected from the model and resuspended 
in 500 µl PBS to which 1.25 µl PMA (20 mM, Biotium, Hay-
ward, CA, USA) was added. These mixtures were incubated for 
10 min in the dark, and exposed to light for 5 min using PhAST 
Blue equipment (GenIUL, Terrassa, Spain). The samples were 
then centrifuged for 5 min at 5,000 rpm, and the pellet resus-
pended in 300 µl Micro Bead solution (MO BIO Laboratories, 
Carlsbad, CA, USA). To obtain “non-viable” cells, bacteria 
were heat-killed at 85°C for 45 min. The viability of these 
bacteria was then assessed by culturing on blood agar plates 
(Becton, Dickinson and Co.).
Microbial genomic DNA isolation
Microbial gDNA was extracted using the MO BIO Ultraclean 
Microbial DNA Isolation Kit (MO BIO Laboratories) with 
modifications, as described previously (10). Microbial gDNA 
samples were stored at –20°C until further processing.
Quantitative PCR
Microbial gDNA was used as template for qPCR amplification 
with SYBR Green using the Bio-Rad CFX Connect apparatus 
(Bio-Rad, Hercules, CA, USA). Details of qPCR and the design 
of strain-specific primers is given in Appendix S11.
16S amplification prior to sequencing
Microbiota samples derived from the skin of the lower back 
contained small amounts of microbial gDNA. Therefore, we 
introduced a pre-amplification step of the V3–V6 regions of 
the 16S rRNA gene, as reported previously (10). Details of am-
plicon generation and used primers are given in Appendix S11.
16S metagenomic library preparation and Illumina sequencing
Illumina 16S metagenomic amplicon libraries were generated 
and sequenced at BaseClear BV (Leiden, The Netherlands). A 
brief description of the procedure is given in Appendix S11.
Fig. 1. Structure of the human cutaneous microbial 
ecosystem model. The model is prepared in a 24-well 
plate. A 2% callus suspension, originating from the heel 
of healthy volunteers, on top of 2% agar (in phosphate-
buffered saline) is the basis of the model. After drying, 
bacteria are inoculated on top of the dead corneocytes 
and cultured at 32°C.
1http://www.medicaljournals.se/acta/content/?doi=10.2340/00015555-2401
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Sequencing data analysis 
Demultiplexed FASTQ files, as provided by BaseClear, were 
first used to generate Illumina paired-end sequence pseudo-
reads by PEAR (31) using the default settings. The resulting 
pyrosequencing data were analysed with a customized QIIME 
v1.2 (32) workflow, as described previously (10). Hierarchical 
(UPGMA) clustering was performed with weighted UniFrac 
as its distance measure; figures resulting from these cluste-
ring analyses were generated using the interactive tree of life 
(iTOL) tool. The PD whole tree alpha diversity was calculated 
by bootstrapping 43,592 reads per sample, and taking the mean 
over 4 bootstrap trials.
Bioluminescent Xen36 analysis 
The bioluminescence of the S. aureus Xen36 strain on the 
model was detected with In Vivo Imaging System (IVIS; Per-
kinElmer, Waltham, MA, USA) apparatus, and analysed with 
Living Image 3.1 software (PerkinElmer, Waltham, MA, USA).
RESULTS
Development and validation of the model: callus as a 
source of nutrients
In vivo, bacteria live and attach to the dead corneocy-
tes of the outer layers of human skin. Therefore, we 
hypothesized that callus would be a natural source of 
nutrients on which microorganisms could survive and 
grow. The model (Fig. 1) was prepared in a 24-well 
plate, using agar (devoid of nutrients) as a basis for cal-
lus suspension and to maintain a sufficiently hydrated 
surface. After drying the applied callus suspension, 
a thin layer of dead corneocytes is present on top of 
the agar, upon which the bacteria are inoculated and 
cultured. The procedure for collection of the bacteria 
from the wells and subsequent analysis by determina-
tion of CFU is shown in Fig. S11.
Regulation of the proliferation rate of the bacteria: 
dynamic vs. static model
In vivo, the number of bacteria on healthy human skin 
remains at a steady-state level, meaning that prolife-
ration rates are low and no overgrowth, as in overt 
infection, occurs. To mimic these conditions in vitro, 
a static model is required. However, if an infectious 
situation needs to be mimicked, a more dynamic model 
is preferred. This could be useful, for instance, when 
antimicrobial compounds are tested. We therefore 
inoculated the model with different numbers of 2 
skin commensals (S. epidermidis and P. acnes) and 2 
relevant skin pathogens (S. aureus and P. aeruginosa), 
cultured them at 32°C, and determined the correlation 
between the starting concentration and the growth of 
these bacteria. The samples were analysed on days 1, 
4 and 7 by counting CFU (Fig. 2). On day 1 CFU/ml 
was comparable for all samples, except for P. acnes, 
regardless of the different starting concentration of the 
inocula. It was shown that the bacteria that were applied 
at a lower concentration proliferated more rapidly than 
those applied at higher concentrations. The 2 highest 
concentrations of P. acnes proliferated 102–103 times 
from day 0 to day 1, the number of CFU/ml at lower 
concentrations decreased at every time-point (Fig. 
2b). From day 1 to day 7, the level of S. epidermidis 
remained steady (108–1010 CFU/ml) for all different 
starting concentrations (Fig. 2a), whereas the level of S. 
aureus diminished approximately 104-fold in this time 
period (Fig. 2c). The highest starting concentrations of 
P. aeruginosa increased at every time-point, the lower 
concentrations remained at a steady level (1021–1022 
CFU/ml), whereas the lowest concentrations decreased 
105 times after day 4 (Fig. 2d).
To determine whether callus is really indispensable 
as a source of nutrients for bacteria, S. epidermidis and 
S. aureus (~109–1010 CFU/ml) were inoculated on the 
model with no callus incorporated. Bacteria still sho-
wed a limited ability to proliferate at day 1; however, 
no viable bacteria were detected on the model without 
callus after 3 days of culture (Fig. S21).
Strain-specific qPCR and propidium monoazide 
treatment optimization
Counting CFU to analyse bacterial survival can be 
applied only when single strains are tested on the callus 
model, as it is difficult to distinguish between different 
bacterial colonies on blood agar plates. Therefore, 
Fig. 2. Effect of the inoculum concentration on bacterial survival. (a) S. epidermidis, (b) P. acnes, (c) S. aureus, and (d) P. aeruginosa inoculated on the 
model in different concentrations ranging from 105 to 1012 colony-forming units (CFU)/ml and analysed on days 1, 4 and 7 by CFU counting. Colours 
represent different inoculation concentrations. Lower starting concentrations of inoculated bacteria resulted in increased growth on day 1, except for 
the lower concentrations of P. acnes. After the first day, all S. epidermidis, S. aureus and P. acnes concentrations followed a similar growth pattern. The 
concentrations of P. aeruginosa follow the same growth pattern up to day 4, then on day 7 the pattern changes depend on the starting concentration. This 
figure represents 1 of 2 separate experiments.
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strain-specific qPCR primers can be used to analyse 
mixed bacterial compositions when, for example, tes-
ting the efficacy of antimicrobial compounds on bac-
terial strains. However, during DNA isolation, gDNA 
from non-viable bacteria is also isolated and skews the 
qPCR data. PMA is able to penetrate the membrane of 
non-viable bacteria and, if exposed to light, binds cova-
lently to gDNA. During isolation of gDNA and qPCR 
analysis, only unbound gDNA from viable cells can be 
isolated and amplified (33). The procedure for bacterial 
collection from the wells and subsequent analysis by 
PMA-qPCR analysis is shown in Fig. S31. To optimize 
the PMA treatment we studied the minimal period of 
light exposure that is effective against dead bacteria, 
without being harmful to viable cells. A 5 min light 
exposure resulted in a negligible effect on the viable 
bacteria compared with the no exposure condition (Fig. 
S41). The PMA procedure is effective to distinguish 
between viable and non-viable S. epidermidis, P. acnes, 
S. aureus, P. aeruginosa and S. pyogenes bacteria (Fig. 
S51). Subsequently, a ratio of viable and non-viable 
bacteria was made for all selected strains in order to 
validate the PMA treatment. Mixtures of viable and 
non-viable bacteria were exposed to PMA and light for 
5 min, followed by gDNA isolation and qPCR analysis 
using Broad Range Universal (BRU) 16S rRNA gene 
primers (Table SI1). Using this PMA-qPCR protocol 
we could reproduce the viable/non-viable cells ratios 
as generated in advance (Fig. 3).
Establishing a “minimal” in vitro microbiome on the 
callus model
Using the callus model and a strain-specific PMA-qPCR 
as a read-out, we aimed to create a “minimal” microbio-
me in vitro. We used S. epidermidis and P. acnes strains, 
the 2 most common and abundant representatives of the 
Firmicutes and Actinobacteria, to create the “minimal” 
microbiome. Both skin commensals were inoculated 
together on the model (108 CFU/ml) and analysed 
on days 1 and 7 by PMA-qPCR using strain-specific 
primers (Table SI1). CFU/ml were calculated based on 
the Ct values using the calibration curve (Fig. S61). S. 
epidermidis showed the same growth curve (Fig. 4a; up 
on day 1, and down again on day 7) as when cultured 
as a single species on the model (Fig. 2a). P. acnes also 
showed the same growth curve in a mixture as cultured 
as a single species on the model (Fig. 2b).
Next, we investigated whether the addition of a pa-
thogen had an effect on the minimal microbiome on the 
model system. S. aureus (108 CFU/ml) was added to 
both commensals on the model (Fig. 4b), but this had 
no quantifiable effect on the growth of S. epidermidis 
and P. acnes. Moreover, S. aureus showed the same 
growth curve as when cultured as a single species on 
the model. However, S. aureus cultured on the model 
(Fig. 2c) grew faster and to higher levels on the first day 
(~log4 scale), than when they were cultured together 
with S. epidermidis and P. acnes (~log2 scale, Fig. 4b). 
On day 7, comparable levels of S. aureus were observed 
in both experiments. The addition of P. aeruginosa 
(108 CFU/ml) to both commensals also did not lead to 
growth pattern-related changes in the minimal micro-
Fig. 3. Effectiveness of propidium monoazide (PMA). PMA-quantitative 
PCR (qPCR) analysis on gDNA from 100% viable (black bars), 10% 
viable (dark grey bars), 1% viable (light greys bars) and 0% viable (white 
bars) S. epidermidis, P. acnes, S. aureus, P. aeruginosa and S. pyogenes 
bacteria. The amount of gDNA detected with PMA-qPCR in the 100% 
viable group was set at 100%. qPCR was performed with BRU 16S rRNA 
gene primers. Data represent the mean ± standard deviation values of 2 
separate experiments.
Fig. 4. A minimal microbiome and pathogens on the callus model. (a) S. epidermidis and P. acnes together form a minimal microbiome that survives for 
at least one week on the model. (b) Addition of S. aureus and (c) P. aeruginosa to the minimal microbiome. Both pathogens showed a growth pattern 
comparable to the strains that were cultured as a single species on the model. No effects of S. aureus and P. aeruginosa on the growth of P. acnes and S. 
epidermidis were found. Values are relative to day 0. Quantitative PCR (qPCR) was performed with strain-specific primers. This figure represents one 
of two separate experiments.
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biome (Fig. 4c); however, P. aeruginosa, like S. aureus, 
showed a decreased proliferation rate when cultured in 
the presence of S. epidermidis and P. acnes.
Application of complete human skin microbiomes to the 
callus model
In vivo microbiomes of the lower back of 2 healthy 
volunteers (HV), obtained by skin swabbing, were 
cultured for one week on the callus model. The lower 
back was selected because of the large diversity of 
bacteria (10). For analysis, PMA-Illumina sequencing 
was applied. The Staphylococcus genus is the most 
abundant, other genera present include Corynebac-
terium, Propionibacterium, and Pseudomonas. The 
microbiota composition remained fairly constant over 
the week, except for the increased relative abundance 
of Corynebacterium species in HV1 on day 7 (Fig. 
S7a1). Moreover, phylogenetic diversity (PD) whole 
tree analysis, a metric for alpha diversity also taking 
taxonomic distance into account, showed that the 
bacterial alpha diversity remained constant over the 7 
days of analysis (Fig. S7b1).
Efficacy of tetracycline on the callus model
To test whether our model is suitable to examine 
antibacterial properties of compounds, we tested the 
efficacy of tetracycline. The results were compared 
with the minimal inhibitory concentration (MIC) found 
in related experiments performed in Mueller Hinton 
culture medium (2 µg/ml for S. aureus and 64 µg/ml 
for S. epidermidis). S. epidermidis and S. aureus were 
cultured in medium and on our model for 24 h together 
with the skin antibiotic tetracycline. The efficacy of 
tetracycline was determined by CFU counting. We 
demonstrated that S. aureus is sensitive to tetracycline 
compared with S. epidermidis (Fig. 5a).
Bioluminescent bacteria for high-throughput analysis 
in the callus model
In order to create a model suitable for high-throughput 
screening, we down-scaled the model to 96-well plates 
and used bioluminescent S. aureus (Xen36). Different 
inoculum concentrations of the strain were applied to 
the model with or without the addition of 2% callus 
suspension (Fig. 5b and c). The different inoculum 
concentrations of Xen36 all reached the same number 
of bacteria on day 1, except for the highest inoculum 
concentration. This trend is similar to the growth of 
non-luminescent S. aureus in 24-well plates (Fig. 2c); 
the lower concentrations more rapidly than the higher 
concentrations. The bacteria showed no growth when 
the model was used without callus.
DISCUSSION
This paper describes a newly developed stratum corne-
um model to study skin microbiota in vitro. The model 
is simple, affordable and amenable to high-throughput 
upscaling, and can be applied to study the growth of 
a single bacterial strain, a mixture of bacteria or a 
complete human skin microbiome. The PMA-qPCR 
analysis method ensures that only DNA from viable 
bacteria is quantified. Moreover, the model can be used 
to study the dynamics of microbial communities, e.g. 
Fig. 5. Possible applications and usability of the callus model. (a) Testing of 
antimicrobial compounds. S. epidermidis and S. aureus were exposed for 24 
h to tetracycline in the callus model. On the callus model, in accordance with 
growth in medium, S. aureus is more vulnerable to tetracycline compared 
with S. epidermidis. Values represent the mean ± standard deviation of 2 
experiments. (b) Applicability of bioluminescent bacteria for high-throughput 
analysis. Bioluminescence of Xen36 measured with In Vivo Imaging 
System (IVIS; PerkinElmer, Waltham, MA, USA) at 0 and 24 h. Dilutions 
of 10 were pipetted on the model with and without 2% callus suspension, 
sample number 1 being the highest concentration of Xen36 on the model. 
(c) Bioluminescence (counts) of Xen36 in (b), analysed with Living Image 
3.1 software.
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following invasion by pathogenic micro-organisms or 
the application of antimicrobial compounds.
The callus-based skin stratum corneum model has 
advantages for studying microbial growth compared 
with human constructed skin equivalents. These cel-
lular models are incubated at 37°C, a temperature that 
strongly favours bacterial growth. This is, however, not 
in accordance with the actual temperature of 32°C typi-
cally present on exposed skin. The model presented here 
can be prepared in advance and stored at 4°C. It consists 
only of 3 components (agar, callus and bacteria), and no 
further expensive matrix and medium components are 
necessary. The bacteria are inoculated and grown on a 
dry surface at 32°C. Our model is primarily designed 
to study the survival and growth of bacteria on the 
stratum corneum of the skin. To study the interaction 
of these bacteria with “living” epidermal cells, in vitro 
skin equivalents are the preferred model. However, the 
addition of recombinant proteins that play a role in the 
normal epidermal host-defence system to our model 
might be a good alternative to study the effect of these 
molecules on the bacterial colonization/composition.
We demonstrated that the callus we used contains 
sufficient nutrients for the growth of the most relevant 
strains and even for an entire skin microbiome. From 
our data, we deduced that callus probably does not con-
tain much sebum components, which are present in vivo 
on specific locations of the human skin (34). Therefore, 
bacteria, such as P. acnes, which live on sebaceous areas 
of the human skin, are able to survive for only one week 
on our model. The addition of sebaceous components 
in future experiments might improve the growth of P. 
acnes on our model. We have also shown that S. epi-
dermidis and S. aureus are not able to survive for more 
than one day without callus (Fig. S21). However, it is 
not clear which nutrients from these dead corneocytes 
are required for bacterial growth. Certainly, lipids in 
the callus are important factors for the bacteria, as we 
observed less bacterial proliferation when delipidized 
callus was used in the model (data not shown).
We created a “minimal” microbiome on our model 
consisting of S. epidermidis and P. acnes, and added 
pathogens (S. aureus and P. aeruginosa) to both of these 
commensals. As our model is suitable for studying the 
survival/growth of these pathogens, the effects of pos-
sible treatments on the pathogen as well as the com-
mensal microbiota could be examined.
Moreover, we demonstrated that a complete in vivo 
skin microbiome can be inoculated on our model. Im-
portantly, the bacterial diversity was relatively stable 
over a period of 7 days (bacterial alpha diversity remai-
ned constant, as shown in Fig. S7b1). Due to the low 
inoculation concentration, the in vivo microbiome was 
able to increase a number of log-scales, but this did not 
strongly affect the bacterial diversity and composition, 
except for the number of Propionibacterium spp., which 
decreased over time, probably due to a lack of sebum or 
lipid components in callus, as discussed above. Further-
more, we observed the presence of Pseudomonas spe-
cies, which were infrequent to absent in our previous 
study (10). However, high levels of Pseudomonas on 
human skin were also reported by others (35). Our skin 
microbiome has a high degree of interpersonal variation 
and therefore it might be coincidental that the 2 samples 
in the present study contain higher Pseudomonas levels 
than the individuals in our previous studies. Alternati-
vely, it is possible that the Pseudomonas sequences are 
derived from contaminations in aqueous solutions from 
the DNA isolation kit. However, the microbiome samp-
les on day 7 do not contain high levels of Pseudomonas 
species. As the microbial DNA from these samples is 
isolated with the same kit, contamination is unlikely.
One of the main advantages of the in vitro skin stratum 
corneum model described here is the ability to control 
the proliferation rates of bacteria applied to the model. 
When we lowered the amount of inoculum, the bacteria 
showed increased growth at the first day (except for P. 
acnes) (Fig. 2). This results in a more dynamic, infec-
tion-like model, suitable for testing antibiotics. As an ex-
ample we used tetracycline to evaluate its antimicrobial 
properties on the model; the MIC value of tetracycline 
in medium is 2 µg/ml for S. aureus and 64 µg/ml for 
S. epidermidis (not sensitive). Comparable values are 
found when S. epidermidis and S. aureus are exposed to 
tetracycline on the model. We therefore concluded that 
this model can be used to assess the antibacterial effects 
of antibiotics and antimicrobial proteins.
Furthermore, we down-scaled our model to a 96-well 
format, using bioluminescent bacteria. Bioluminescent 
bacteria (S. aureus Xen36 strain) could be detected on 
the model in a rapid and non-laborious way. The survi-
val trend of the bioluminescent Xen36 strain is similar 
to the non-luminescent S. aureus strain that we used in 
24-well plates (Fig. 2c), suggesting that our model can 
be used as a high-throughput system.
Possible applications of the stratum corneum model 
described here include intervention experiments to 
change disease-related microbiota compositions; for 
example, by prebiotics, probiotics or targeted antibio-
tics. In conclusion, we postulate that the in vitro skin 
stratum corneum model presented here will contribute 
to the understanding of diseases linked to bacterial 
colonization and/or infection.
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